DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Papatheodoridis GV, Sypsa V, Dalekos G. , et al.
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.
J Hepatol 2018;
68 (06) 1129-1136
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.